These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 32229661)

  • 1. Exploring the role of adipsin in statin-induced glucose intolerance: a prospective open label study.
    Maini J; Rehan HS; Yadav M; Gupta LK
    Drug Metab Pers Ther; 2020 Apr; 35(1):. PubMed ID: 32229661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between serum adipsin and the first phase of glucose-stimulated insulin secretion in individuals with different glucose tolerance.
    Zhou Q; Ge Q; Ding Y; Qu H; Wei H; Wu R; Yao L; Wei Q; Feng Z; Long J; Deng H
    J Diabetes Investig; 2018 Sep; 9(5):1128-1134. PubMed ID: 29432659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance.
    Sasaki J; Ikeda Y; Kuribayashi T; Kajiwara K; Biro S; Yamamoto K; Ageta M; Kobori S; Saikawa T; Otonari T; Kono S
    Clin Ther; 2008 Jun; 30(6):1089-101. PubMed ID: 18640465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alirocumab therapy in individuals with type 2 diabetes mellitus and atherosclerotic cardiovascular disease: analysis of the ODYSSEY DM-DYSLIPIDEMIA and DM-INSULIN studies.
    Ray KK; Del Prato S; Müller-Wieland D; Cariou B; Colhoun HM; Tinahones FJ; Domenger C; Letierce A; Mandel J; Samuel R; Bujas-Bobanovic M; Leiter LA
    Cardiovasc Diabetol; 2019 Nov; 18(1):149. PubMed ID: 31706300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statin therapy on glycemic control in type 2 diabetic patients: A network meta-analysis.
    Cui JY; Zhou RR; Han S; Wang TS; Wang LQ; Xie XH
    J Clin Pharm Ther; 2018 Aug; 43(4):556-570. PubMed ID: 29733433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do statins beneficially or adversely affect glucose homeostasis?
    Kostapanos MS; Liamis GL; Milionis HJ; Elisaf MS
    Curr Vasc Pharmacol; 2010 Sep; 8(5):612-31. PubMed ID: 20507274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adipsin is an adipokine that improves β cell function in diabetes.
    Lo JC; Ljubicic S; Leibiger B; Kern M; Leibiger IB; Moede T; Kelly ME; Chatterjee Bhowmick D; Murano I; Cohen P; Banks AS; Khandekar MJ; Dietrich A; Flier JS; Cinti S; Blüher M; Danial NN; Berggren PO; Spiegelman BM
    Cell; 2014 Jul; 158(1):41-53. PubMed ID: 24995977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Switching From Statin Monotherapy to Ezetimibe/Simvastatin Combination Therapy Compared With Other Intensified Lipid-Lowering Strategies on Lipoprotein Subclasses in Diabetic Patients With Symptomatic Cardiovascular Disease.
    Le NA; Tomassini JE; Tershakovec AM; Neff DR; Wilson PW
    J Am Heart Assoc; 2015 Oct; 4(10):e001675. PubMed ID: 26486166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statin therapy worsens insulin sensitivity in women with polycystic ovary syndrome (PCOS): a prospective, randomized, double-blind, placebo-controlled study.
    Puurunen J; Piltonen T; Puukka K; Ruokonen A; Savolainen MJ; Bloigu R; Morin-Papunen L; Tapanainen JS
    J Clin Endocrinol Metab; 2013 Dec; 98(12):4798-807. PubMed ID: 24152688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of new-onset diabetes with 1 mg versus 4 mg pitavastatin in patients at high risk of developing diabetes during a 3-year follow-up.
    Jeong HS; Hong SJ; Son S; An H; Kook H; Joo HJ; Park JH; Yu CW; Lim DS
    Cardiovasc Diabetol; 2019 Nov; 18(1):162. PubMed ID: 31752850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statins Are Associated With Increased Insulin Resistance and Secretion.
    Abbasi F; Lamendola C; Harris CS; Harris V; Tsai MS; Tripathi P; Abbas F; Reaven GM; Reaven PD; Snyder MP; Kim SH; Knowles JW
    Arterioscler Thromb Vasc Biol; 2021 Nov; 41(11):2786-2797. PubMed ID: 34433298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adipsin Serum Concentrations and Adipose Tissue Expression in People with Obesity and Type 2 Diabetes.
    Milek M; Moulla Y; Kern M; Stroh C; Dietrich A; Schön MR; Gärtner D; Lohmann T; Dressler M; Kovacs P; Stumvoll M; Blüher M; Guiu-Jurado E
    Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of rosuvastatin combined with olmesartan, irbesartan, or telmisartan on indices of glucose metabolism in Greek adults with impaired fasting glucose, hypertension, and mixed hyperlipidemia: a 24-week, randomized, open-label, prospective study.
    Rizos CV; Milionis HJ; Kostapanos MS; Florentin M; Kostara CE; Elisaf MS; Liberopoulos EN
    Clin Ther; 2010 Mar; 32(3):492-505. PubMed ID: 20399986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of rosuvastatin in low-density lipoprotein cholesterol lowering and National Cholesterol Education Program Adult Treatment Panel guideline III LDL-C goal attainment compared to other statins among diabetes mellitus patients: a retrospective study using an electronic medical records dataset in the United States.
    Fox KM; Gandhi SK; Ohsfeldt RL; Blasetto JW; Bays HE
    Curr Med Res Opin; 2007 Sep; 23(9):2125-33. PubMed ID: 17655813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of statin therapy on incident type 2 diabetes mellitus in patients with clinically manifest vascular disease.
    van de Woestijne AP; van der Graaf Y; Westerink J; Nathoe HM; Visseren FL
    Am J Cardiol; 2015 Feb; 115(4):441-6. PubMed ID: 25554536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma triglyceride determination can identify increased risk of statin-induced type 2 diabetes: a hypothesis.
    Armato J; Ruby R; Reaven G
    Atherosclerosis; 2015 Apr; 239(2):401-4. PubMed ID: 25682039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reciprocal changes of serum adispin and visfatin levels in patients with type 2 diabetes after an overnight fast.
    Legakis I; Mantzouridis T; Bouboulis G; Chrousos GP
    Arch Endocrinol Metab; 2016 Feb; 60(1):76-8. PubMed ID: 26909486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statin treatment is associated with insulin sensitivity decrease in type 1 diabetes mellitus: A prospective, observational 56-month follow-up study.
    Duvnjak L; Blaslov K
    J Clin Lipidol; 2016; 10(4):1004-1010. PubMed ID: 27578133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and Validation of a Model to Predict Absolute Vascular Risk Reduction by Moderate-Intensity Statin Therapy in Individual Patients With Type 2 Diabetes Mellitus: The Anglo Scandinavian Cardiac Outcomes Trial, Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial, and Collaborative Atorvastatin Diabetes Study.
    Kaasenbrood L; Poulter NR; Sever PS; Colhoun HM; Livingstone SJ; Boekholdt SM; Pressel SL; Davis BR; van der Graaf Y; Visseren FL;
    Circ Cardiovasc Qual Outcomes; 2016 May; 9(3):213-21. PubMed ID: 27174798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Lipoproteins, Insulin Resistance, and Rosuvastatin With Incident Type 2 Diabetes Mellitus : Secondary Analysis of a Randomized Clinical Trial.
    Dugani SB; Akinkuolie AO; Paynter N; Glynn RJ; Ridker PM; Mora S
    JAMA Cardiol; 2016 May; 1(2):136-45. PubMed ID: 27347563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.